White blood cellcount and the risk of coronary heart diseaseand all-causemortality in elderly men 16
499 ~ 503[1996]
White blood cellcount and cardiovascular disease 267
1253 ~ 1256[1992]
White blood cell countand clustered features of metabolic syndrome in Japanesemale office workers 52
213 ~ 218[2002]
Weight reductionincreases plasma levels of an adipose-derived anti-inflammatoryprotein, adiponectin 86
3815 ~ 3819[2001]
Tumor necrosis factor-α: a key component of the obesity-diabetes link 43
1271 ~ 1278[1994]
TheTNF-a gene NcoI polymorphism influences the relationshipamong insulin resistance, percent body fat, and increasedserum leptin levels 46
1468 ~ 1472[1997]
The white blood cell count: its relationship toplasma insulin and other cardiovascular risk factors inhealthy male individuals 239
435 ~ 441[1996]
The relationship ofwhite blood cell count to other cardiovascular risk factors 19
881 ~ 888[1990]
The pathogenesis of atherosclerosis: a perspectivefor the 1990s 362
801 ~ 809[1993]
The leukocyte count: correlates and relationshipto coronary risk factors 19
889 ~ 893[1990]
The leukocyecount as a predictor of myocardial infection 290
1275 ~ 1278[1974]
The fatderivedhormone adiponectin reverses insulin resistance associatedwith both lipoatrophy and obesity 7
941 ~ 946[2001]
The differential effect of food intake and β-adrenergicstimulation on adipose-derived hormones and cytokines inman 84
2126 ~ 2133[1999]
Subcutaneous adiposetissue releases interleukin-6, but not tumor necrosis factor-α in vivo 82
4196 ~ 4200[1997]
Regulation of the acute phase response by cytokines 36
611 ~ 622[1993]
Proteolytic cleavageproduct of 30-kDa adipocyte complement-related proteinincreases fatty acid oxidation in muscle and causes weightloss in mice 98
2005 ~ 2010[2001]
Production of C-reactive protein and risk of coronaryevents in stable and unstable angina 349
462 ~ 466[1997]
Plasma concentrations of a novel,adipose-specific protein, adiponectin, in type 2 diabetic patients 20
1595 ~ 1599[2000]
Omental and subcutaneousadipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid 83
847 ~ 850[1998]
Lifetime smoking exposure affectsthe association of C-reactive protein with cardiovasculardisease risk factors and subclinical disease in healthyelderly subjects 17
2167 ~ 2176[1997]
Leukocytes and the risk of ischemic disease 257
2318 ~ 2324[1987]
Leukocytecount correlates in middle-aged adults 136
Leukocyte count and fibrinogen are associated with carotidand femoral intima-media thickness in a risk populationfor diabetes 56
277 ~ 283[2002]
Interleukin-6 as a central mediator of cardiovascularrisk associated with chronic inflammation, smoking,diabetes, and visceral obesity: down-regulation with essentialfatty acids, ethanol and pentoxifylline 52
465 ~ 477[1999]
In vivo measurements of"apparent viscosity" and microvessel hematocrit in themesentery of the cat 19
297 ~ 319[1980]
Importance of TNF-α and leptin in obesity and insulin resistance: a hypothesison the impact of physical exercise 4
77 ~ 94[1998]
Hyperinsulinemia:the key feature of a cardiovascular and metabolicsyndrome 34
416 ~ 422[1991]
Growth-promoting effects of insulin-likegrowth factor-1 (IGF-1) on hematopoietic cells: overexpressionof introduced IGF-1 receptor abrogates interleukin-3dependency of murine factor-dependent cells by a liganddependentmechanism 78
921 ~ 929[1991]
Genetic analysis of the IRS: pleiotropic effects ofgenes influencing insulin levels on lipoprotein and obesitymeasures 16
281 ~ 288[1996]
Fibrinogen, viscosity, andwhite blood cell count are major risk factors for ischemicheart disease 83
Expert Panel on Detection, Evaluation, and Treatment ofHigh Blood Choesterol in Adults. Executive summary of thethird report of the National Cholesterol Education Program(NCEP) expert panel on detection, evaluation, and treatmentof high blood choesterol in adults (Adult TreatmentPanel Ⅲ). 285
2486 ~ 2497[2001]
Executive summary of the Third Report of the NationalCholesterol Education Program (NCEP) Expert Panel onDetection, Evaluation, and Treatment of Hight Blood Cholesterolin Adults (Adult Treatment Panel III) 285
2486 ~ 2496[2001]
Chronic subclinical inflammation as partof the insulin resistance syndrome 102
42 ~ 47[2000]
C-reactiveprotein in healthy subjects: associations with obesity,insulin resistance, and endothelial dysfunction 19
972 ~ 978[1999]
C-reactive protein,a sensitive marker of inflammation, predicts future risk ofco-ronary heart disease in initially healthy midle agedmen 99
237 ~ 242[1999]
C reactive protein and its relation to cardiovascular riskfactors: a population based cross sectional study 312
1061 ~ 1065[1996]
Approach to lipoprotein management in 2001National Cholesterol Guidelines 90 (Suppl)
Adipocyte-derived plasma protein,adiponectin, suppresses lipid accumulation and class Ascavenger receptor expression in human monocyte-derivedmacrophages 103
1057 ~ 1063[2001]
Acute systemic inflammationimpairs endothelium-dependent dilatation in humans 102